These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Preparation of specific, potent antilymphocyte serum in the horse using dog thymocytes. Braf ZF, Smellie WA, Williams GM, Hume DM. Surg Forum; 1967 Sep; 18():227-9. PubMed ID: 4866923 [No Abstract] [Full Text] [Related]
8. Antilymphocyte serum (ALS) as an immunosuppressive agent in transplantation of the canine larynx. I. Preparation of antilymphocyte serum. Mogi G, Harvey JE, Ohyama M, Ueda N, Ogura JH. Laryngoscope; 1972 Jan; 82(1):61-73. PubMed ID: 4109440 [No Abstract] [Full Text] [Related]
9. Effect of antilymphocyte serum on renal allograft survival in dogs with special reference to the cytotoxic titer and immunosuppressive activity. Matsukura M, Sekiguchi M, Endo S, Kurosawa T, Koishi T. Jpn J Exp Med; 1971 Aug; 41(4):369-73. PubMed ID: 4936584 [No Abstract] [Full Text] [Related]
11. The effect of adult thymectomy in dogs on the immunosuppressive activity of antilymphocyte serum (ALS). Mogi G, Harvey JE, Ogura JH. Laryngoscope; 1974 Jan; 84(1):78-83. PubMed ID: 4589567 [No Abstract] [Full Text] [Related]
12. Use of anti-lymphocyte serum to prolong renal allograft survival in dogs. Fujimoto Y, Miura T, Uchida H, Inou T. Jpn J Exp Med; 1967 Jun; 37(3):205-16. PubMed ID: 4869985 [No Abstract] [Full Text] [Related]
13. Immunosuppressive effect of antilymphocyte serum on the canine lung allograft as a single immunosuppressive agent. Iwahashi H, Nagaya H, Sealy WC, Sieker HO. Transplantation; 1970 Jun; 9(6):558-65. PubMed ID: 4911415 [No Abstract] [Full Text] [Related]
14. [Characteristics of antilymphocyte serum prepared with spleen- or thymus cells]. Collste LG, Groth KG, Holmström B, Kashiwagi N, Lundgren G, Obel N, Schantz B, Svehag SE. Nord Med; 1971 Jul 29; 86(30):919-20. PubMed ID: 4936832 [No Abstract] [Full Text] [Related]
16. The prolongation of canine renal homograft survival by heterologous serum. Hinchey EJ, Bliss JQ. Can Med Assoc J; 1966 Dec 03; 95(23):1169-71. PubMed ID: 5331897 [Abstract] [Full Text] [Related]
19. The ocular immune response. II. Immune rejection of penetrating corneal homografts. Early versus late treatment with antilymphocyte serum. Waltman SR, Burde RM, Faulkner HW. Transplantation; 1969 Aug 03; 8(2):147-51. PubMed ID: 4896328 [No Abstract] [Full Text] [Related]
20. Antilymphoid sera in renal allotransplantation. Shorter RG, Hallenbeck GA, Nava C, O'Kane H, DeWeerd JH, Johnson WJ. Arch Surg; 1968 Aug 03; 97(2):323-9. PubMed ID: 4173066 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]